e Commission and other regulatory authorities.
The Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.
--FINANCIAL TABLES FOLLOW--
CHINA-BIOTICS, INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts expressed in US Dollars)
Three months ended June 30,
2008 2007
Net sales $ 11,370,657 $ 9,515,333
Cost of sales (3,258,669) (2,650,972)
Gross profit $ 8,111,988 $ 6,864,361
Operating expenses:
Selling expenses $ (2,369,859) $ (1,316,344)
General and administrative expenses (1,426,797) (809,564)
Total operating expenses $ (3,796,656) $ (2,125,908)
Income from operations $ 4,315,332 $ 4,738,453
Other income and expenses:
Changes in the fair value of
embedded derivatives (1,239,000) --
Other income $ 1,538,889 $ 71,660
Other expenses -- (6,924)
Total other income (expenses) $299,889 $ 64,736
Income before taxes $ 4,615,221 $ 4,803,189
Provision for income taxes (1,378,471) (1,262,956)
Net income $ 3,236,750 $ 3,540,233
Earnings per share:
Basic $ 0.19 $ 0.21
Diluted $ 0.23 $ 0.21
'/>"/>SOURCE China-Biotics, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related biology technology :1.
China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results2.
China-Biotics, Inc. Files Application for Nasdaq Listing3.
China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 20084.
China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results5.
China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 20086.
China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results7.
China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company8.
China-Biotics, Inc. to Present at Two Upcoming Investor Conferences9.
China-Biotics, Inc. Completes Foundation for Its New Plant10.
China-Biotics, Inc. Reports Third Quarter 2008 Financial Results11.
China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results